National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 7/22/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Stephen Behrman, MD

None

None

None

None

7/16/2014

Al B. Benson III, MD, FACP, FASCO

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Advanced Accelerator Applications SA;
Alchemia;
Astellas;
Gilead;
Infinity

Bayer HealthCare;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Cleveland Biolabs;
Gilead;
McKinsey;
Spectrum Pharmaceuticals;
Precision Therapeutics, Inc.

None

None

9/5/2013

Jennifer Burns

None

None

None

None

7/10/2014

E. Gabriela Chiorean, MD

None

Celgene Corporation

None

None

6/20/2013

Vincent Chung, MD

None

Genomic Health, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

10/7/2013

Steven J. Cohen, MD

Genentech, Inc.

Bristol-Myers Squibb Company;
Genentech, Inc.;
Genentech, Inc.

None

None

10/7/2013

Brian Czito, MD

Abbott Laboratories;
Amgen Inc.

None

None

None

8/17/2012

Anitra Engebretson

None

None

None

None

10/3/2013

Mary Feng, MD

None

None

None

None

10/4/2013

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

William G. Hawkins, MD

Adura;
Gilead;
New Link Genetics

None

None

None

10/3/2013

Joseph Herman, MD

Elekta

None

None

None

6/26/2013

John P. Hoffman, MD

None

None

None

None

4/11/2013

Andrew H. Ko, MD

Celgene Corporation;
ImClone Systems Incorporated;
Infinity Pharmaceuticals

Celgene Corporation;
Oncogenex;
Threshold Pharmaceuticals

None

None

9/12/2013

Srinadh Komanduri, MD

None

None

None

None

1/23/2014

Albert Koong, MD, PhD

Varian Medical Systems, Inc.

Varian Medical Systems, Inc.

None

None

10/3/2013

Andrew M. Lowy, MD

None

None

None

None

7/2/2013

Wen Wee Ma, MD

Celgene Corporation

Celgene Corporation

None

None

10/4/2013

Mokenge P. Malafa, MD, FACS

None

None

None

None

10/3/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

Nipun B. Merchant, MD

None

None

None

None

1/23/2014

Sean J. Mulvihill, MD

National Cancer Institute

None

None

None

10/3/2013

Peter Muscarella II, MD

GlobeImmune;
Stryker

None

None

None

7/9/2014

Eric K. Nakakura, MD

None

None

None

None

6/26/2014

Eileen M. O'Reilly, MD

Celgene Corporation;
OncoMed Pharmaceuticals;
Aduro;
Incyte;
Momemta;
Polaris;
sanofi-aventis U.S.

Celgene Corporation;
silenseed;
Pharmacyclics;
sanofi-aventis U.S.

None

None

6/27/2014

Jorge Obando, MD

None

Merck & Co., Inc.

None

None

10/7/2013

Martha B. Pitman, MD

None

None

None

None

1/2/2014

Sushanth Reddy, MD

None

None

None

None

7/8/2014

Aaron R. Sasson, MD

None

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/10/2014

Margaret A. Tempero, MD

Bayer HealthCare

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Covidien AG;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
Asuragen;
Bionomics;
NuCana BioMed;
Peregrine;
Quest Diagnostic

None

Celgene Corporation

2/24/2014

Sarika Trikha

None

None

None

None

5/19/2014

Colin D Weekes, MD, PhD

Amgen Inc.;
Bayer HealthCare;
Celgene Corporation;
Genentech, Inc.;
OncoMed Pharmaceuticals

Celgene Corporation

None

None

10/3/2013

Robert A. Wolff, MD

None

Precision Medicine Research Associates (PMRA)

McGraw-Hill

Clovis Oncology - Rucaparib Pancreatic Advisory Board;
London Health Science Centre Surgical Grand Rounds

7/17/2014

Brian M. Wolpin, MD, MPH

None

None

None

None

10/8/2013